octenisept®
- Broad spectrum of antiseptic efficacy
- Fast onset of action
- Very good skin and mucous membrane tolerance
- Suitable for infants and premature babies*
- Safe use during pregnancy (after the first trimester)¹
- Painless and colourless treatment
Further information
Fields of Application
Wound treatment
Antiseptic treatment of traumatic, acute, chronic, surgical and burn wounds.
Mucous membrane antiseptic
- prior to diagnostic and surgical interventions in the anogenital (e.g. before obliteration of haemorrids), the urogenital area (e.g. before placing an intra-uterine device (IUD), the vaginal area, before prenatal, intranatal and postnatal manipulations) and in the oral cavity (e.g. before tooth extractions)
- before placing urinary tract catheters
- for preop. skin antisepsis in the area close to mucous membranes
| Application area | ready-to-use |
|---|---|
| ano- and urogenital | 1 min. |
| before bladder catheterisation | 1 min. |
| dabbing of the oral cavity | 1 min. |
| rinsing of the oral cavity | 20 sec. |
| skin antisepsis beforecaesarean operation | 2 min. |
| wounds | 1 min. |
Instructions for use
- Moisturize the treated area evenly and thoroughly with the antiseptic.
- Swab method: Rub concerned areas with saturated swabs. Swabbing is the prefered method of application.
- Spray method: In individual cases spray octenisept® directly on poorly accessible areas of the skin and mucous membrane. Make sure all areas are evenly moistened.
- octenisept® may also be applied by rinsing the oral cavity
Microbiological efficacy
| Efficacy | Test method | Test Condition | ready-to-use |
|---|---|---|---|
| Bacteria, Yeast and Mycobacteria | |||
| bactericidal | EN 13727 dirty conditions | 15 sec. | |
| Candida albicans | EN 13624 dirty conditions | 15 sec. | |
| MRSA | EN 13727 dirty conditions | 15 sec. | |
| Pseudomonas aeruginosa | EN 13727 dirty conditions | 15 sec. | |
| yeasticidal | EN 13624 dirty conditions | 15 sec. | |
| Virus | |||
| Herpes simplex virus | EN 14476 dirty conditions | 15 sec. | |
| virucidal against enveloped viruses | EN 14476 dirty conditions | 15 sec. | |
Product data
100 g solution contains: 0.1 g Octenidine dihydrochloride, 2 g 2-Phenoxyethanol (Ph.Eur.)
Other components: Cocamidopropyl Betaine, Sodium D Gluconate, Glycerol 85%, Sodium Chloride, Sodium Hydroxide, Purified Water
Chemical-physical data
Special advice
- To prevent possible tissue injury, the product must not be injected into the deep tissue using a syringe. The product is intended for superficial use only (application by swab or spray pump).
- octenisept® should not be used for irrigating the abdominal cavity (e.g. intraoperatively), the urinary bladder and nose or eardrum.
- Do not swallow octenisept®.
- Do not enter it into the blood circuit, e.g. by being accidently injected.
- Do not mix octenisept® with other compounds.
- Do not use octenisept® in combination with PVP-iodine based antiseptics, as this may cause severe brown to purple discoloration.
- Bandages and incision foils can be applied after octenisept® has dried off completely.
- In rare cases octenisept® may cause slight burning, redness, itching and feel of warmth.
- octenisept® can be heated up to body temperature.
- octenisept® expires three years after opening.
- Once the container has been opened octenisept® should not be used for more than three years but not beyond the expiry date.
- As a general prinicple: administrating of any pharmaceuticals within the first trimester of pregnancy should be carried out under strict indication and medical supervision.
- Microbiological efficacies on specific germs have only been carried out in in-vitro tests.
- Usage of octenisept® in the eye should be avoided. In case of contact with eyes, rinse immediately with plenty of water.
- Do not freeze.
- octenisept® should be used with caution in premature infants (see package insert)
Information for order
| Item | Delivery form | Item no. |
|---|---|---|
| octenisept® 100 ml bottle | 20 / carton(s) | on request |
| octenisept® with spray pump 250 ml bottle | 10 / carton(s) | on request |
| octenisept® clinic package 250 ml bottle | 10 / carton(s) | on request |
| octenisept® 500 ml bottle | 20 / carton(s) | on request |
| octenisept® 1 l bottle | 10 / carton(s) | on request |
| octenisept® clinic package 500 ml bottle | 20 / carton(s) | on request |
| octenisept® 250 ml bottle | 10 / carton(s) | on request |
| octenisept® clinic package 1 l bottle | 10 / carton(s) | on request |
| octenisept® clinic package with spray pump 250 ml bottle | 10 / carton(s) | on request |
Application aids
| Item | Delivery form | Item |
|---|---|---|
wall bracket plastics 500ml  | 1 | 134411 |
wall bracket plastics 1l | 1 | 134416 |
Environmental information
schülke manufactures its products using advanced and safe production processes while maintaining high quality standards.
¹Briese et al. (2010): Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosi during pregnancy; in Arch Gynecol Obste
*Please read the package leaflet.
Downloads
octenisept®
Active substances: octenidine dihydrochloride, phenoxyethanol (Ph.Eur.). Composition: 100 g solution contain: 0.1 g octenidine dihydrochloride, 2.0 g phenoxyethanol (Ph.Eur.). Other ingredients: cocamidopropylbetaine, sodium D gluconate, glycerol 85%, sodium chloride, sodium hydroxide, purified water. Indications: For repeated, short-term antiseptic treatment of mucous membranes and adjacent tissues prior to diagnostic and surgical procedures - in the ano-genital region including the vagina, vulva and glans penis as well as prior to bladder catheterization - in the oral cavity. For short-term supporting therapy of interdigital mycotic infections and adjuvant antiseptic wound treatment. Contraindications: octenisept® may not be used in cases of hypersensitivity to any of the components of the preparation. octenisept® should not be used for rinsing the abdominal cavity (e.g. intra-operatively) or the bladder, nor the tympanic membrane. Undesirable effects: rare: burning, redness, itching and warmth at the application site, very rare: allergic contact reaction, e.g. temporary redness at the application site; frequency unknown: after lavage of deep wounds with a syringe, persistent edema, erythema and also tissue necrosis have been reported, in some cases requiring surgical revision. Rinsing of the oral cavity may cause a transitory bitter sensation. Revision 11/22
To prevent possible tissue injury, the product must not be injected into the deep tissue using a syringe. The product is intended for superficial use only (application by swab or spray pump).
Schülke & Mayr GmbH, 22840 Norderstedt, Germany, Tel. +49 40 52100-666, info@schuelke.com